FDA Allows [Some] Pharmacies to Distribute Medication Abortion, Ish

Plus: Idaho ban upheld, South Carolina ban struck down

Here’s another edition of Hard to Believe It’s Only Tuesday, a weekly roundup of the top headlines, tweets (for now!), toks, takes, and more in abortion news. You can always email me ([email protected]) or DM me on instagram with action items, takes, and news clips.

The big takeaway: Major week for medication abortion news. The FDA will permit pharmacies to dispense mifepristone, part of a two-medication regimen with misoprostol for medication abortion. (Misoprostol can also be used on its own to end a pregnancy.) This is very big, because until now, mife could only be distributed by certified online pharmacies and doctors and clinics. Now, CVS and Walgreens have said they’ll get certified to distribute the meds where abortion is legal. It’s also not big enough: see the Takes section for details from medical experts, researchers, and legal scholars. Basically: there are still pharmaceutical hoops to jump, and the FDA continues to treat mifepristone differently purely because of its association with abortion. The other big news is that the Justice Department has said that federal law allows delivery of medication abortion anywhere via the U.S. Postal Service.

The Top Headlines

The Takes

  • ANSIRH’s Ushma D. Upadhyay is in the Los Angeles Times with a thoughtful yes/but on the FDA’s mife update, writing: “This week’s announcement at least shows an intent to expand access through retail pharmacies. But the FDA is maintaining other restrictions on this essential medicine without medical justification. Instead of yielding to anti-abortion pressures, the FDA needs to follow the science on mifepristone.” And We Testify’s Renee Bracey Sherman, ANSIRH’s Dr. Daniel Grossman, and American University abortion researcher Tracy Weitz are in The Nation with a similar call: “We need to follow the decades of data showing that medication abortion safe enough to be made available over the counter for everyone. Until then, we need our communities to speak up and call on their local pharmacies to stock abortion pills so they are available as soon as they are needed. This is a moment for public pressure and demand. If we want abortion access for all, we’re going to have to fight for it. In turn, we need the FDA to stop offering us crumbs and bureaucratic barriers. Follow the science and make medication abortion available for real this time.”

  • Legal scholars David S. Cohen, Greer Donley, and Rachel Rebouche are in Slate with a warning of the FDA’s inadequate incrementalism on medication abortion: “… this announcement has come amidst a legal campaign to outlaw mifepristone by judicial fiat—which, if successful, will render the FDA’s decision meaningless.”

  • Texas-based researchers Shetal Vohra-Gupta and Kari White are in the Austin American-Statesman with an op-ed connecting the dismal findings of the state’s Maternal Mortality and Morbidity Review Committee to abortion restrictions, institutional-medical racism, and more: “It should not be this dangerous to be pregnant in Texas. State leaders need to take bold actions and adopt policies that are supported both by evidence and by the majority of Texans. They can start by extending Medicaid coverage for 12 months after pregnancy ends and passing legislation to fairly compensate doulas for all who want them. A Texas that ensures that pregnancy and the postpartum period is safer for all residents – and especially for Black and low-income Texans – can’t come soon enough.”

The Tweets/Toks/Grams

  • Had to do a double take on this tweet from the Kansas Abortion Fund, great work plugging into the Spare ~ zeitgeist ~

The Fuck Are We Supposed to Do About It?

That’s all for this week. I’m sure I’ve missed something you’d like to see featured in this roundup, for I am but one woman with a computer and an abortion-news-induced drinking problem. Holler at me — [email protected], or DM me on Instagram, and I’ll try to add follow-ups as I’m able.